CURLF vs NAGE
Curaleaf Holdings, Inc. and Niagen Bioscience, Inc., side by side — 5 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | CURLF | NAGE |
|---|---|---|
| Revenue | $1.3B | $129.4M |
| Net income | $-231.1M | $17.4M |
| Gross margin | 49.8% | 64.3% |
| Net margin | −18.0% | 13.4% |
| Return on equity | −28.6% | 28.3% |
| Diluted EPS | −$0.35 | $0.20 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | $74.3M | · |
| Equity | $756.4M | $76.5M |
| Net debt / equity | 0.59× | · |
| Current ratio | 1.52× | 4.86× |
| Revenue CAGR 5y | · | 16.9% |
| Profit CAGR 5y | · | · |
CURLF bills 9.8× the revenue of NAGE, and CURLF closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
5 years side by side
| Fiscal year | CURLF | NAGE |
|---|---|---|
| FY2025 | $1.3B | $129.4M |
| FY2024 | $1.3B | $99.6M |
| FY2023 | $1.3B | $83.6M |
| FY2022 | $1.3B | $72.0M |
| FY2021 | $1.2B | $67.4M |
Bottom line
| Fiscal year | CURLF | NAGE |
|---|---|---|
| FY2025 | $-231.1M | $17.4M |
| FY2024 | $-215.4M | $8.6M |
| FY2023 | $-281.2M | $-4.9M |
| FY2022 | $-370.1M | $-16.5M |
| FY2021 | $-205.9M | $-27.1M |
5 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$1,138,712,000 | CURLF |
| FY2024 | +$1,234,702,000 | CURLF |
| FY2023 | +$1,263,062,000 | CURLF |
| FY2022 | +$1,203,370,000 | CURLF |
| FY2021 | +$1,128,538,000 | CURLF |
CURLF has reported the higher revenue in every one of these 5 fiscal years. The gap has widened since the earliest year compared.
5 of 16 comparable fiscal years — a year missing data on either side is not counted.
5 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −31.4 pp | NAGE |
| FY2024 | −25.2 pp | NAGE |
| FY2023 | −15.7 pp | NAGE |
| FY2022 | −6.6 pp | NAGE |
| FY2021 | +22.3 pp | CURLF |
The higher net margin has changed hands between CURLF and NAGE over this period.
5 of 16 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
NAGE's net margin has been more volatile than CURLF's over the 5 comparable fiscal years — 20.0 percentage points of standard deviation against 4.7.
5 of 16 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between CURLF and NAGE over these 5 fiscal years — CURLF led in 1 and NAGE in 4.
5 of 16 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
NAGE's return on equity has been more volatile than CURLF's over the 5 comparable fiscal years — 52.5 percentage points of standard deviation against 5.2.
5 of 16 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between CURLF and NAGE over these 5 fiscal years — CURLF led in 2 and NAGE in 3.
5 of 16 comparable fiscal years — a year missing data on either side is not counted.